Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Robson

Showing results (271-280 of 299) with videos related to

Pageof 30
Sort By:
NPJ Breast Cancer|August 21, 2019
Homologous recombination DNA repair defects in <i>PALB2-</i>associated breast cancersAnqi Li, Felipe C Geyer, Pedro Blecua, et al.
JCO Precision Oncology|July 12, 2021
Prevalence and Characterization of Biallelic and Monoallelic <i>NTHL1</i> and <i>MSH3</i> Variant Carriers From a Pan-Cancer Patient PopulationErin E Salo-Mullen, Anna Maio, Semanti Mukherjee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2019
Cancer Susceptibility Mutations in Patients With Urothelial MalignanciesMaria I Carlo, Vignesh Ravichandran, Preethi Srinavasan, et al.
NPJ Breast Cancer|November 23, 2019
Erratum: Publisher Correction: Homologous recombination DNA repair defects in <i>PALB2</i>-associated breast cancersAnqi Li, Felipe C Geyer, Pedro Blecua, et al.
JAMA Oncology|July 2, 2016
Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA MutationsCatherine A Shu, Malcolm C Pike, Anjali R Jotwani, et al.
Cancer Discovery|December 24, 2021
Cancer-Causative Mutations Occurring in Early EmbryogenesisFresia Pareja, Ryan N Ptashkin, David N Brown, et al.
Nature Genetics|November 6, 2021
The context-specific role of germline pathogenicity in tumorigenesisPreethi Srinivasan, Chaitanya Bandlamudi, Philip Jonsson, et al.
Biorxiv : the Preprint Server for Biology|September 10, 2024
Tumor suppressor heterozygosity and homologous recombination deficiency mediate resistance to front-line therapy in breast cancerAnton Safonov, Antonio Marra, Chaitanya Bandlamudi, et al.
JCO Precision Oncology|September 22, 2023
Germline Pathogenic Variants and Genetic Counseling by Ancestry in Patients With Epithelial Ovarian CancerTiffany Y Sia, Anna Maio, Yelena M Kemel, et al.
JCO Precision Oncology|August 22, 2017
Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision MakingWassim Abida, Joshua Armenia, Anuradha Gopalan, et al.
Pageof 30

Showing results (271-280 of 299) with videos related to

Sort By:
Pageof 30
NPJ Breast Cancer|August 21, 2019
Homologous recombination DNA repair defects in <i>PALB2-</i>associated breast cancersAnqi Li, Felipe C Geyer, Pedro Blecua, et al.
JCO Precision Oncology|July 12, 2021
Prevalence and Characterization of Biallelic and Monoallelic <i>NTHL1</i> and <i>MSH3</i> Variant Carriers From a Pan-Cancer Patient PopulationErin E Salo-Mullen, Anna Maio, Semanti Mukherjee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2019
Cancer Susceptibility Mutations in Patients With Urothelial MalignanciesMaria I Carlo, Vignesh Ravichandran, Preethi Srinavasan, et al.
NPJ Breast Cancer|November 23, 2019
Erratum: Publisher Correction: Homologous recombination DNA repair defects in <i>PALB2</i>-associated breast cancersAnqi Li, Felipe C Geyer, Pedro Blecua, et al.
JAMA Oncology|July 2, 2016
Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA MutationsCatherine A Shu, Malcolm C Pike, Anjali R Jotwani, et al.
Cancer Discovery|December 24, 2021
Cancer-Causative Mutations Occurring in Early EmbryogenesisFresia Pareja, Ryan N Ptashkin, David N Brown, et al.
Nature Genetics|November 6, 2021
The context-specific role of germline pathogenicity in tumorigenesisPreethi Srinivasan, Chaitanya Bandlamudi, Philip Jonsson, et al.
Biorxiv : the Preprint Server for Biology|September 10, 2024
Tumor suppressor heterozygosity and homologous recombination deficiency mediate resistance to front-line therapy in breast cancerAnton Safonov, Antonio Marra, Chaitanya Bandlamudi, et al.
JCO Precision Oncology|September 22, 2023
Germline Pathogenic Variants and Genetic Counseling by Ancestry in Patients With Epithelial Ovarian CancerTiffany Y Sia, Anna Maio, Yelena M Kemel, et al.
JCO Precision Oncology|August 22, 2017
Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision MakingWassim Abida, Joshua Armenia, Anuradha Gopalan, et al.
Pageof 30